Pulmonx, Corp. (NASDAQ: LUNG), Redwood City, CA – FDA Inspections

Inspection records and compliance data for Pulmonx, Corp. in Redwood City, California. 3 FDA inspections on record, 1 Form 483, last inspected July 02, 2026. Publicly traded as NASDAQ: LUNG.

Company Profile

This profile covers Pulmonx, Corp. based in Redwood City, California, United States.

FDA Inspection History

FDA inspections: 3
OAI: 0
VAI: 0
NAI: 2
Unclassified: 1
Form 483s: 1
Warning letters: 0

First inspected February 21, 2014. Last inspected July 2, 2026.

Most cited issue areas

Lack of or inadequate process validation1 inspection
Procedures not adequately established or maintained1 inspection

FDA inspections (3)

Date	Result	FDA center(s)	Insp. #
July 2, 2026	Not classified	Medical Devices & Rad Health	1316830
November 8, 2016	NAI	Medical Devices & Rad Health · Postmarket Assurance: Devices	993003
February 21, 2014	NAI	Medical Devices & Rad Health · Postmarket Assurance: Devices	862529

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

IFGFIT INC.

Neomatrix, LLC

Edge Systems Corp

PANTHER ORTHOPEDICS, INC.

Sendx Medical Inc

Oralten Corporation

Thayer Intellectual Property, Inc.

Thomas T Haider

International Medical Devices, Inc

Spectrum International, Inc.